| Beamline 5.0.2 |
|
|
|
|
|
|
| |
|
|
|
|
| August 2008 |
|
|
|
|
| |
|
Users |
Scheduled Time |
# Shifts |
PI |
User Contact |
| |
|
|
|
|
| 1 |
Friday |
|
|
|
| |
|
|
|
|
| 2 |
Saturday |
|
|
2 |
|
| 3 |
Sunday |
|
|
B |
|
| 4 |
Monday |
|
|
U |
|
| 5 |
Tuesday |
|
|
N |
|
| 6 |
Wednesday |
|
|
C |
|
| 7 |
Thursday |
|
|
H |
|
| 8 |
Friday |
|
|
|
| 9 |
Saturday |
|
|
|
| 10 |
Sunday |
|
|
|
| |
|
|
|
|
| 11 |
Monday |
|
|
|
| |
|
|
|
|
| 12 |
Tuesday |
Start Up |
8am-2pm |
|
|
|
| |
|
Staff |
2pm-9am |
2 |
|
|
| 13 |
Wednesday |
NIH SGX - TB
SGx |
10am - 9am |
3 |
Hung |
Yu |
| 14 |
Thursday |
Amgen |
10am - 9am |
3 |
Jordan |
|
| 15 |
Friday |
Vertex |
10am - 9am |
3 |
Jacobs |
|
| 16 |
Saturday |
Roche |
10am - 9am |
3 |
|
|
| 17 |
Sunday |
GlaxoSmithKline
Staff-G |
10am - Midnight |
2 |
Williams |
|
| |
|
|
|
|
| 18 |
Monday |
|
|
|
| 19 |
Tuesday |
|
|
|
| |
|
|
|
|
| 20 |
Wednesday |
Start Up |
8am-2pm |
|
|
|
| |
|
Pfizer |
2pm-9am |
2 |
Knighton |
|
| 21 |
Thursday |
Scripps Staff-T |
GlaxoSmithKline |
10am - 9am (1) |
3 |
Carmel/Williams |
|
| 22 |
Friday |
deCODE |
10am - 9am |
3 |
Kim |
|
| 23 |
Saturday |
OHSU |
10am - 9am |
3 |
Gouaux |
|
| 24 |
Sunday |
OHSU |
10am - 9am |
3 |
Gouaux |
|
| |
|
|
|
|
| 25 |
Monday |
|
|
|
| |
|
|
|
|
| 26 |
Tuesday |
Start Up |
8am-2pm |
|
|
|
| |
|
NovartisE |
2pm-9am |
2 |
Bussiere |
|
| 27 |
Wednesday |
Gilead |
10am - 9am |
3 |
McGrath |
|
| 28 |
Thursday |
Amgen |
10am - 9am |
3 |
Jordan |
|
| 29 |
Friday |
Genentech |
10am - 9am |
3 |
Eigenbrot |
|
| 30 |
Saturday |
UCLA |
10am - 9am |
3 |
Abramson |
|
| 31 |
Sunday |
GSK Staff-TBD |
10am - 11pm |
2 |
Williams |
Elkins |
| |
|
|
|
|
| |
Legend |
|
|
|
|
|
|
| |
|
PRT (SC=Service Crystallography) |
|
(1)
First user 10am-1:30am; second user 1:30am-9am |
| |
|
GU |
|
(2)
First user 2pm-11pm; second user 11pm-9am. |
| |
|
Start Up |
|
(3)
First user 10am-4:30pm; second user
4:30pm to 11pm. |
| |
|
Staff |
|
|
| |
|
No Beamtime |
|
46 shifts |
|
| |
* Non PRT's scheduled on
canceled or unused beamtime |
|
|
|
|
|
|
|
|
|
|
|
|